Literature DB >> 14633237

Qualitative similarities in cognitive impairment associated with 24 h of sustained wakefulness and a blood alcohol concentration of 0.05%.

Marina G Falleti1, Paul Maruff, Alexander Collie, David G Darby, Michael McStephen.   

Abstract

Previous studies that have quantified fatigue-related cognitive impairment as blood alcohol concentration (BAC) equivalents have been limited by two issues: the effect of practice on tests of cognition and, more importantly, the statistic used to quantify change in cognitive performance. The current study addressed these issues by adopting an ABACA design, which allowed for the adequate control of practice effects, and by using effect size metrics, which enabled direct comparisons to be made in performance impairments as a result of fatigue (i.e. sustained wakefulness of 24 h) and alcohol (i.e. BAC of 0.05%). Cognitive performance under the fatigue and alcohol conditions required the use of the CogState battery. It was demonstrated that fatigue caused greater impairment than alcohol on the speed of continuous attention and memory and learning, and on the accuracy of complex matching. Alcohol was more detrimental than fatigue only on the accuracy of memory and learning. Performances on the remaining tasks were the same for both the fatigue and alcohol conditions. These differences and similarities in performance impairment are discussed emphasizing the deleterious cognitive effects of relatively short periods of sustained wakefulness.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633237     DOI: 10.1111/j.1365-2869.2003.00363.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  31 in total

Review 1.  Young women's anterior cruciate ligament injuries: an expanded model and prevention paradigm.

Authors:  Diane L Elliot; Linn Goldberg; Kerry S Kuehl
Journal:  Sports Med       Date:  2010-05-01       Impact factor: 11.136

2.  Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer.

Authors:  Sunita K Patel; Adrienne M Meier; Nathaniel Fernandez; Tracy T Y Lo; Colleen Moore; Nicole Delgado
Journal:  Clin Neuropsychol       Date:  2017-01-12       Impact factor: 3.535

3.  Orienting and alerting: effect of 24 h of prolonged wakefulness.

Authors:  Maria Casagrande; Diana Martella; Enrico Di Pace; Fabio Pirri; Francesco Guadalupi
Journal:  Exp Brain Res       Date:  2005-11-25       Impact factor: 1.972

4.  Effects of heading exposure and previous concussions on neuropsychological performance among Norwegian elite footballers.

Authors:  T M Straume-Naesheim; T E Andersen; J Dvorak; R Bahr
Journal:  Br J Sports Med       Date:  2005-08       Impact factor: 13.800

5.  Reproducibility of computer based neuropsychological testing among Norwegian elite football players.

Authors:  T M Straume-Naesheim; T E Andersen; R Bahr
Journal:  Br J Sports Med       Date:  2005-08       Impact factor: 13.800

6.  Cognition in the days following concussion: comparison of symptomatic versus asymptomatic athletes.

Authors:  A Collie; M Makdissi; P Maruff; K Bennell; P McCrory
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

7.  Does history of concussion affect current cognitive status?

Authors:  A Collie; P McCrory; M Makdissi
Journal:  Br J Sports Med       Date:  2006-06       Impact factor: 13.800

8.  Cognitive deterioration associated with an expedition in an extreme desert environment.

Authors:  P Maruff; P Snyder; M McStephen; A Collie; D Darby
Journal:  Br J Sports Med       Date:  2006-06       Impact factor: 13.800

9.  Salivary biomarkers of physical fatigue as markers of sleep deprivation.

Authors:  Darren J Michael; Bianca Valle; Jennifer Cox; John E Kalns; Donovan L Fogt
Journal:  J Clin Sleep Med       Date:  2013-12-15       Impact factor: 4.062

10.  Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial.

Authors:  Kelly-Anne Phillips; Julie Aldridge; Karin Ribi; Zhuoxin Sun; Alastair Thompson; Vernon Harvey; Beat Thürlimann; Fatima Cardoso; Olivia Pagani; Alan S Coates; Aron Goldhirsch; Karen N Price; Richard D Gelber; Jürg Bernhard
Journal:  Breast Cancer Res Treat       Date:  2010-11-03       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.